SR 12813
Chemical Name: [[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis-phosphonic acid tetraethyl ester
Purity: ≥99%
Biological Activity
SR 12813 is a pregnane X receptor (PXR) agonist (EC50 values are 200 and 700 nM for human and rabbit PXR respectively). Activates the farnesoid X receptor (FXR) at μM concentrations. Displays hypocholesterolemic activity via enhanced degradation of HMG-CoA reductase.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Berkhout et al.
J.Biol.Chem., 1996;271:14376 -
Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore modeling and virtual screening to "in vivo" biological activity.
Lemaire et al.
Mol.Pharmacol., 2007;72:572 -
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.
Jones et al.
Mol.Pharmacol., 2000;14:27
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for SR 12813
The citations listed below are publications that use Tocris products. Selected citations for SR 12813 include:
1 Citation: Showing 1 - 1
-
Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds.
Authors: Delfosse Et al.
Nat Commun 2015;6:8089
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for SR 12813
There are currently no reviews for this product. Be the first to review SR 12813 and earn rewards!
Have you used SR 12813?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image